Showing results (611-620 of 2,503) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|March 14, 2022
A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mgYutaka Seino, Hideaki Miyoshi, Heidrun Bosch Traberg, et al.Journal of Diabetes Investigation|April 15, 2022
Transition of cardiometabolic status and the risk of type 2 diabetes mellitus among middle-aged and older Chinese: A national cohort studyYiwen Qiu, Qian Yi, Shuting Li, et al.Journal of Diabetes Investigation|April 8, 2022
The age of death in Japanese patients with type 2 and type 1 diabetes: A descriptive epidemiological studyYuichi Nishioka, Shinichiro Kubo, Sadanori Okada, et al.Journal of Diabetes Investigation|April 22, 2022
Roles of glucose-dependent insulinotropic polypeptide in diet-induced obesityYusuke Seino, Yuji YamazakiJournal of Diabetes Investigation|October 12, 2021
Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitusLiyin Zhang, Yaling Xu, Xiaofang Jiang, et al.Journal of Diabetes Investigation|October 8, 2021
Fasting plasma glucose level in the range of 90-99 mg/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2Chihiro Munekawa, Hiroshi Okada, Masahide Hamaguchi, et al.Journal of Diabetes Investigation|February 17, 2022
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass indexDaisuke Yabe, Yuichiro Yamada, Kohei Kaku, et al.Journal of Diabetes Investigation|April 13, 2022
Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetesRan Yoshimura, Tomoko Nakagami, Yukiko Hasegawa, et al.Journal of Diabetes Investigation|February 3, 2022
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trialsDaisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, et al.Journal of Diabetes Investigation|February 24, 2022
Impact of diabetes on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary interventionZhen Ye, Qin Chen, Jiaxin Zhong, et al.Pageof 251